Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
EBIATLong-Term Debt RepaymentsWages, Salaries and Other
Ratios

Kraig Biocraft Laboratories (KBLB) Shares Outstanding (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Shares Outstanding for 11 consecutive years, with $990.1 million as the latest value for Q3 2022.

  • Quarterly Shares Outstanding rose 10.31% to $990.1 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $990.1 million through Sep 2022, up 10.31% year-over-year, with the annual reading at $1.1 million for FY2021, N/A changed from the prior year.
  • Shares Outstanding hit $990.1 million in Q3 2022 for Kraig Biocraft Laboratories, up from $1.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $990.1 million in Q3 2022 to a low of $2.0 in Q1 2019.
  • Historically, Shares Outstanding has averaged $492.1 million across 4 years, with a median of $816.9 million in 2018.
  • Biggest five-year swings in Shares Outstanding: crashed 100.0% in 2018 and later soared 56115450.0% in 2019.
  • Year by year, Shares Outstanding stood at $1.1 million in 2018, then changed by 0.0% to $1.1 million in 2019, then changed by 0.0% to $1.1 million in 2021, then surged by 88120.27% to $990.1 million in 2022.
  • Business Quant data shows Shares Outstanding for KBLB at $990.1 million in Q3 2022, $1.1 million in Q2 2022, and $950.9 million in Q1 2022.